Yizhuang SDIC

Beijing Yizhuang International Investment & Development Co., Ltd., commonly known as Yizhuang SDIC or E-Town Capital, is a state-owned investment and industrial development platform established by the Beijing Economic-Technological Development Area (BDA). Founded in 2009, the company serves as a strategic engine for high-tech industrial growth in Beijing, with a major focus on the biopharmaceutical and healthcare sectors. Yizhuang SDIC operates through a comprehensive model of direct investment, fund management, and industrial park operations, most notably managing the Beijing Yizhuang Biomedical Park (E-Town BIO). The company provides a full-chain innovation service system, including incubation, R&D platforms, and CDMO services for cell and gene therapy, monoclonal antibodies, and small molecules. As a leading institutional investor, it has supported numerous prominent biotech firms such as Jacobio Pharmaceuticals, Xuanzhu Biopharmaceutical, and Bohui Biotech, while also participating in national-level industrial funds.